Connection

Kelly Hunt to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications Kelly Hunt has written about Drug Resistance, Neoplasm.
Kelly Hunt
Connection Strength
0.020
Drug Resistance, Neoplasm
  1. A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA. 2011 May 11; 305(18):1873-81.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.